Company intelligence / Profile preview
Cellbricks Therapeutics
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
Overview
Cellbricks is a specialized biotechnology company focused on the development of 3D bioprinted human tissues for regenerative medicine and therapeutic applications. Utilizing a proprietary high-resolution stereolithographic bioprinting technology, the company creates complex, vascularized tissue structures that mimic natural human biology. Their primary therapeutic focus is on soft tissue reconstruction, offering solutions for patients requiring tissue replacement due to oncology, trauma, or congenital defects. Beyond therapeutics, Cellbricks provides 'Organ-on-a-Chip' models and bioprinted scaffolds to support drug development and academic research. The company aims to revolutionize the field of tissue engineering by providing off-the-shelf biological implants that integrate seamlessly with the patient's own body.
- Therapeutic areas
- DermatologyWomen's HealthOther
- Modalities
- Cell therapyHydrogel-based drug delivery therapy3D Bioprinting
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Cellbricks Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellbricks Therapeutics.